Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Dupixent repeats as top pharma ad brand, rankings largely unchanged in May
Medical Marketing and Media
Tue, 06/11/24 - 10:49 pm
pharma advertising
DTC advertising
Dupixent
Regeneron
Sanofi
Companies to watch for potential M&As in 2024
BioSpace
Wed, 06/5/24 - 11:31 am
M&A
Vertex Pharmaceuticals
Regeneron
Biogen
Moderna Therapeutics
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
Who Will the Next “Big Pharma” Players Be?
BioSpace
Wed, 05/29/24 - 11:21 am
Big Pharma
Vertex Pharmaceuticals
Regeneron
Moderna Therapeutics
Zoetis
BioNTech
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
ASCO 2024
Regeneron
clinical trials
bispecific antibodies
REGN7075
solid tumors
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
FDA approves two biosimilars to blockbuster eye drug Eylea
Reuters
Mon, 05/20/24 - 11:23 am
Regeneron
Eylea
FDA
biosimilars
Biocon Biologics
Yesafli
Opuviz
Samsung BioLogics
Biogen
Dupixent recaptures top Rx, OTC pharma brand spot in April
Medical Marketing and Media
Wed, 05/8/24 - 11:03 pm
DTC advertising
Dupixent
Sanofi
Regeneron
ASGCT24: Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids
BioSpace
Wed, 05/8/24 - 11:33 am
Regeneron
DB-OTO
genetic deafness
gene therapy
ASGCT
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
Fierce Biotech
Thu, 05/2/24 - 10:14 pm
Regeneron
Eli Lilly
Zepbound
obesity
trevogrumab
bimagrumab
Regeneron Misses Q1 Earnings on Lower-Than-Expected Eylea Sales
BioSpace
Thu, 05/2/24 - 10:10 pm
Regeneron
Eylea
earnings
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters
Thu, 05/2/24 - 11:26 am
Regeneron
earnings
Eylea
Dupixent’s DU More campaign breathes life into asthma treatment space
Medical Marketing and Media
Mon, 04/29/24 - 09:53 am
Dupixent
DTC advertising
Sanofi
Regeneron
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
AbbVie
Rinvoq
Regeneron
Sanofi
Dupixent
atopic dermatitis
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive
Thu, 04/25/24 - 11:31 am
Regeneron
Mammoth Biosciences
CRISPR
gene editing
Regeneron to defend against DOJ complaint on drug-price manipulation
Yahoo/Reuters
Tue, 04/16/24 - 10:02 pm
Regeneron
DOJ
drug pricing
Eylea
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
Fierce Biotech
Mon, 04/15/24 - 11:04 am
Regeneron
funding
venture capital
biotech
DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea
BioSpace
Thu, 04/11/24 - 11:27 am
DOJ
Regeneron
Medicare
Eylea
drug pricing
False Claims Act
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »